Article
Critical molecular pathways in cancer stem cells of chronic myeloid leukemia.
Leukemia - 1 Sept 2010
Chen Y, Peng C, Sullivan C, Li D, Li S
Abstract excerpt
Inhibition of BCR-ABL with kinase inhibitors in the treatment of Philadelphia-positive (Ph(+)) chronic myeloid leukemia (CML) is highly effective in controlling but not curing the disease. This is largely due to the inability of these kinase inhibitors to kill leukemia stem cells (LSCs) responsib...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
